Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Acute Kidney Injury | Commentary

Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: cross-talk between two organ support machines

Authors: Kianoush Kashani, Marlies Ostermann

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Following a substantial increase in the utilization of extracorporeal membrane oxygenation (ECMO) during the last decade, its associated benefits and complications, including acute kidney injury have become more apparent. Acute kidney injury requiring dialysis during the ECMO treatment is very common and is associated with adverse outcomes. Cross talk between ECMO and dialysis equipment has been debated in the literature in order to enhance the quality of dialysis and avoid its potential adverse events.
Na et al. recently published the results of a prospective experiment by using three different methods for integration of the continuous renal replacement therapy device into the ECMO circuit. In this experiment, the investigators showed that by using three different connection strategies between continuous renal replacement therapy device and ECMO and the utilization of three separate structures of pressure control lines, the dialyzer lifespan could be optimized.
In this commentary, following a brief review of the ECMO and dialysis devices history and cross talk, we discuss the findings by Na et al. and provide additional insights for future investigations.
Literature
1.
go back to reference Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg. 2003;76(6):S2224–9.CrossRef Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg. 2003;76(6):S2224–9.CrossRef
2.
go back to reference Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, Morris AH, Peirce EC 2nd, Thomas AN, Proctor HJ, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193–6.CrossRef Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, Morris AH, Peirce EC 2nd, Thomas AN, Proctor HJ, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193–6.CrossRef
3.
go back to reference Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.CrossRef Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.CrossRef
4.
go back to reference McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, et al. Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002-2012. Semin Thorac Cardiovasc Surg. 2015;27(2):81–8.CrossRef McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, et al. Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002-2012. Semin Thorac Cardiovasc Surg. 2015;27(2):81–8.CrossRef
5.
go back to reference Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA, Fortenberry JD, Paden ML. Extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(1):60–7.CrossRef Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA, Fortenberry JD, Paden ML. Extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(1):60–7.CrossRef
6.
go back to reference Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Curr Opin Crit Care. 2018;24(6):493–503.CrossRef Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Curr Opin Crit Care. 2018;24(6):493–503.CrossRef
7.
go back to reference Antonucci E, Lamanna I, Fagnoul D, Vincent J-L, De Backer D, Silvio Taccone F. The impact of renal failure and renal replacement therapy on outcome during extracorporeal membrane oxygenation therapy. Artif Organs. 2016;40(8):746–54.CrossRef Antonucci E, Lamanna I, Fagnoul D, Vincent J-L, De Backer D, Silvio Taccone F. The impact of renal failure and renal replacement therapy on outcome during extracorporeal membrane oxygenation therapy. Artif Organs. 2016;40(8):746–54.CrossRef
8.
go back to reference Devasagayaraj R, Cavarocchi NC, Hirose H. Does acute kidney injury affect survival in adults with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation? Perfusion. 2018;33(5):375–82.CrossRef Devasagayaraj R, Cavarocchi NC, Hirose H. Does acute kidney injury affect survival in adults with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation? Perfusion. 2018;33(5):375–82.CrossRef
9.
go back to reference de Tymowski C, Augustin P, Houissa H, Allou N, Montravers P, Delzongle A, Pellenc Q, Desmard M. CRRT connected to ECMO: managing high pressures. ASAIO J. 2017;63(1):48–52.CrossRef de Tymowski C, Augustin P, Houissa H, Allou N, Montravers P, Delzongle A, Pellenc Q, Desmard M. CRRT connected to ECMO: managing high pressures. ASAIO J. 2017;63(1):48–52.CrossRef
10.
go back to reference Lequier L, Horton SB, McMullan DM, Bartlett RH. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S7–S12.CrossRef Lequier L, Horton SB, McMullan DM, Bartlett RH. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S7–S12.CrossRef
11.
go back to reference Na SJ, Choi HJ, Chung CR, Cho YH, Jang HR, Suh GY, Jeon K. Using additional pressure control lines when connecting a continuous renal replacement therapy device to an extracorporeal membrane oxygenation circuit. BMC Nephrol. 2018;19(1):369.CrossRef Na SJ, Choi HJ, Chung CR, Cho YH, Jang HR, Suh GY, Jeon K. Using additional pressure control lines when connecting a continuous renal replacement therapy device to an extracorporeal membrane oxygenation circuit. BMC Nephrol. 2018;19(1):369.CrossRef
Metadata
Title
Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: cross-talk between two organ support machines
Authors
Kianoush Kashani
Marlies Ostermann
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1602-9

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.